SimmondsEJ, ConwaySP, GhoneimATM, RossH, LittlewoodJM. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom.Arch Dis Child1990; 65: 874–77.
7.
WhitefordML, WilkinsonJD, McCollJHOutcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.Thorax1995; 50: 1194–8.
8.
MuhdiK, EdenboroughFP, GumeryLOutcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.Thorax1996; 51: 374–7.
9.
GovanJRW, NelsonJW. Microbiology of lung infection in cystic fibrosis.Br Med Bull1992; 48: 912–30.
10.
HolmesB.The identification of Pseudomonas cepacia and its occurrence in clinical material.J Appl Bact1986; 61: 299–314.
11.
BassettDCJ, DicksonJAS, HuntGH. Infection of Holter valve by Pseudomonas-contaminated chlorhexidine.Lancet1973; i: 1263–4.
WeblingD.D.'A.. Rapid resolution of cryptococcal meningitis during superimposed Pseudomonas cepacia infection.Med J Aust1978; 2: 336–7.
15.
HobsonR, GouldI, GovanJ.Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media.Eur J Clin Microbiol Infect Dis1995; 14: 908–11.
16.
Millar-JonesL, PaullA, SaundersZ, GoodchildMC. Transmission of Pseudomonas cepacia among cystic fibrosis patients.Lancet1992; 340: 491.
17.
LiPumaJJ, DasenSE, NielsonDW, SternRC, StullTL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.Lancet1990; 336: 1094–6.
18.
SmythA, HeafD, CorkillJ, HartT, SissonP, FreemanR.Transmission of Pseudomonas cepacia by social contact in cystic fibrosis.Lancet1993; 342: 434–5.
19.
GovanJRW, BrownPH, MaddisonJEvidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.Lancet1993; 342: 15–19.
20.
GovanJRW. Infection control issues: ‘tight control’.Pediatr Pulmonol1996; Suppl l3: 111–12.
21.
LarsenGY, StullTL, BurnsJL. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.J Clin Microbiol1993; 31: 788–92.
22.
KostmanJR, EdlundTD, LiPumaJJ, StullTL. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping.J Clin Microbiol1991; 29: 2084–7.
23.
RyleyHC, Millar-JonesL, PaullA, WeekesJ.Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping.J Clin Microbiol1995; 43: 436–41.
24.
SteinbachS, SunL, Ru-ZhangJTransmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.N Engl J Med1994; 331: 981–7.
25.
WoodsCR. Brain abscesses and other intracranial suppurative complications.Adv Pediatr Infect Dis1995; 10: 41–79.
26.
KlineKW. Brain abscess in a patient with cystic fibrosis.Pediatr Infect Dis J1985; 4: 72–3.
27.
RamirezJC, PattersonGA, WintonTL, de HoyosAL, MillerJD, MaurerJR. Bilateral lung transplantation for cystic fibrosis.J Thorac Cardiovasc Surg1992; 103: 287–94.
28.
LewistonN, KingV, UmetsuDCystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage.Transplant Proc1991; 23: 1207–8.
29.
NoyesBE, MichaelsMG, KurlandG, ArmitageJM, OrensteinDM. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis.Chest1994; 105: 1888–91.
30.
DettelbachMA, HirschBE, WeissmanJL. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis.Otolaryngol Head Neck Surg1994; 111: 528–32.
31.
FlumePA, EganTM, ParadowskiLJ, DetterbeckFC, ThompsonJT, YankaskasJR. Infectious complications of lung transplantation. Impact of cystic fibrosis.Am J Resp Crit Care Med1994; 149: 1601–7.
32.
EganJJ, McNeilK, BooklessBPost-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia.Lancet1994; 344: 552–3.
EganTM. Lung transplantation in cystic fibrosis.Semin Respir Infect1992; 7: 227–39.
35.
WhiteheadB, ReesP, SorensenKIncidence of obliterative bronchiolitis after heart-lung transplantation in children.J Heart Lung Transplant1994; 13: 903–8.
36.
NovickRJ, AndreassianB, ShafersH-JPulmonary retransplantation for obliterative bronchilitis. Intermediate-term results of a North American–European series.J Thorac Cardiovasc Surg1994; 107: 755–63.
37.
ScottJP, HigenbottamTW, SharpiesLRisk factors for obliterative bronchiolitis in heart—lung transplant recipients.Transplantation1991; 51: 813–7.
38.
NovickRJ, AhmadD, MenkisAHThe importance of acquired diffuse bronchomalacia in heart—lung transplant recipients with obliterative bronchiolitis.J Thorac Cardiovasc Surg1991; 101: 643–8.
SadeghiAM, GuthanerDF, WexlerLHealing and revascularisation of the tracheal anastomosis following heart–lung transplantation.Surg Forum1982; 33: 236–8.
41.
Balfour-LynnIM, MartinI, WhiteheadBF, ReesPG, ElliottMJ, de LevalMR. Heart-lung transplantation for patients under 10 with cystic fibrosis.Arch Dis Child1997; 76: 38–40.
42.
WhiteheadBF, de LevalMR. Paediatric lung transplantation: the agony and the ecstasy.Thorax1994; 49: 437–9.